Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Nerve blocks may help heart surgery patients breathe easier after operation

NCT ID NCT05958823

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether two types of nerve blocks (SAP and PECS) can reduce pain and shorten the time patients need a breathing tube after heart bypass surgery. 243 adults undergoing open heart surgery received either a nerve block or standard pain medication. Researchers measured pain scores, opioid use, and recovery times to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nerve blocks (serratus anterior plane block and pectoral nerve blocks I-II)
What this could lead to
If effective, these nerve blocks could become a standard way to reduce pain and speed recovery after heart surgery.
What could go wrong
This is a completed trial, but results are not yet published. Nerve blocks carry small risks like bleeding or infection, and may not work better than standard painkillers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

243 people

The number who actually took part.

Started

Jun 2023

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Agreeing to participate in the study, * 20-65 years old * ASA I-II-III * Open heart surgery Exclusion Criteria: * Refusal to participate in the study * 20 years old, over 65 years old * Pregnancy * Presence of bleeding diathesis * Liver or kidney failure * Receiving effective treatment on immunity * Immune suppressed * Those with BMI ≥30

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder Pain, Postoperative Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Van Yuzuncu Yil University

    Van, Turkey, 65100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.